Test Compendium

Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.

Yes

Displaying 126 - 150 of 475

Colorectal Cancer 50 Genes NGS Panel

Molecular

Colorectal Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR,


Endometrial Cancer 50 Genes NGS Panel

Molecular

Endometrial Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1,


Esophageal Cancer 50 Genes NGS Panel

Molecular

Esophageal Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR,


Gastric Cancer 50 Genes NGS Panel

Molecular

Gastric Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR,


GIST Cancer 50 Genes NGS Panel

Molecular

GIST Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR,


Head & Neck Cancer 50 Genes NGS Panel

Molecular

Head & Neck Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1,


Liver & Biliary Cancers 50 Genes NGS Panel

Molecular

Liver & Biliary Cancers 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2


Melanoma 50 Genes NGS Panel

Molecular

Melanoma 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR, ERBB2,


Non-Small Cell Lung Cancer 50 Genes NGS Panel

Molecular

Non-Small Cell Lung Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2


Ovarian Cancer 50 Genes NGS Panel

Molecular

Ovarian Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR,


Pancreatic Cancer 50 Genes NGS Panel

Molecular

Pancreatic Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR,


Soft Tissue Cancer 50 Genes NGS Panel

Molecular

Soft Tissue Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR,


Thyroid Cancer 50 Genes NGS Panel

Molecular

Thyroid Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR,


CREBBP single gene test

Molecular

CREBBP single gene test Methodology Molecular Test Description Genes CREBBP Disease Intestinal cancer, skin cancer, stomach cancer, bladder cancer, lung adenocarcinoma, colon adenocarcinoma, and breast


CSF3R Mutation Analysis

Molecular

CSF3R Mutation Analysis Methodology Molecular Test Description Genes CSF3R Disease Atypical Chronic Myeloid Leukemia and Chronic Neutrophilic Leukemia, Severe congenital neutropenia (Kostmann syndrome)Next


CTNNB1 Mutation Analysis

Molecular

CTNNB1 Mutation Analysis Methodology Molecular Test Description Genes CTNNB1 Disease Endometrial endometrioid adenocarcinoma, lung adenocarcinoma, colon adenocarcinoma, prostate adenocarcinoma, and hepatocellular


DDR2 single gene test

Molecular

DDR2 single gene test Methodology Molecular Test Description Genes DDR2 Disease Lung adenocarcinoma, breast invasive ductal carcinoma, colon adenocarcinoma, endometrial endometrioid adenocarcinoma, and


DDX3X single gene test

Molecular

DDX3X single gene test Methodology Molecular Test Description Genes DDX3X (exons 7-9,11,14) Disease Endometrial cancer, skin cancer, melanoma and stomach cancer. Diffuse large B-cell lymphoma, chronic


DNMT3A Mutation Analysis

Molecular

DNMT3A Mutation Analysis Methodology Molecular Test Description Genes DNMT3A Disease Cytogenetically normal acute myeloid leukemia, T-cell acute lymphoblastic leukemia, Systemic mastocytosis, DNMT3A overgrowth


EGFR Mutation Analysis

Molecular

EGFR Mutation Analysis Methodology Molecular Test Description Genes EGFR common variants (eg: exon 19 LREA deletion, L858R, T790M, G719A, G719S, L861Q) Disease Non-small cell lung cancer, Glioblastoma,


ERBB2 Mutation Analysis

Molecular

ERBB2 Mutation Analysis Alternative Name c-ERBB2 (HER-2/neu) Methodology Molecular Test Description Genes ERBB2 Disease Breast invasive ductal carcinoma, lung adenocarcinoma, colon adenocarcinoma, and


ERBB3 single gene test

Molecular

ERBB3 single gene test Methodology Molecular Test Description Genes ERBB3 Disease Colon adenocarcinoma, bladder urothelial carcinoma, breast invasive ductal carcinoma, lung adenocarcinoma, and endometrial


ERBB4 single gene test

Molecular

ERBB4 single gene test Methodology Molecular Test Description Genes ERBB4 Disease Lung adenocarcinoma, colon adenocarcinoma, cutaneous melanoma, melanoma, and breast invasive ductal carcinomaMolecular


ERG single gene test

Molecular

ERG single gene test Methodology Molecular Test Description Genes ERG Disease Acute myeloid leukemia (AML), Ewing sarcoma, soft tissue sarcoma, prostate adenocarcinoma, lung adenocarcinoma, colon adenocarcinoma,


ESR1 single gene test

Molecular

ESR1 single gene test Methodology Molecular Test Description Genes ESR1 Disease Breast invasive ductal carcinoma, invasive breast carcinoma, colon adenocarcinoma, lung adenocarcinoma, and endometrial endometrioid


Discover more.

A Model Experience

With core values rooted in service and integrity, our leadership team sets the bar high.

We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.

Accredited and Certified

siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).

We also hold select state licensure where required.